Fate Therapeutics, Inc.

NASDAQ: FATE
$32.42
-$0.42 (-1.3%)
Closing price August 10, 2022

Wedbush's Top Picks After ASH Annual Meeting
The American Society of Hematology (ASH) hosted its 61st annual meeting and one of the biggest biotech events earlier this week in Orlando, Florida.
Chris Lange
2 years ago
Last Updated: 2 years ago

Why Fate Therapeutics Is One of ASH's Biggest Winners
Fate Therapeutics shares jumped on Monday after the firm announced new preclinical data for its off-the-shelf, multi-antigen targeting natural killer cell product candidate derived from a clonal...
Chris Lange
2 years ago
Last Updated: 2 years ago

Top Analyst Upgrades and Downgrades: Analog Devices, Blackstone, Bloom Energy, Cleveland-Cliffs, Ford, Micron, PG&E, Snap, VMWare and More
Tuesday's top analyst upgrades, downgrades and initiations included Analog Devices, Blackstone, Bloom Energy, Cleveland-Cliffs, Ford, Micron Technology, PG&E, Snap and VMWare.
Jon C. Ogg
2 years ago
Last Updated: 2 years ago